STE · XBRL financial data

STERIS financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (STE's year ends in late March)

In millions of dollars	Q2 FY24Sep 30, 2023	Q3 FY24Dec 31, 2023	Q4 FY24Mar 31, 2024	Q1 FY25Jun 30, 2024	Q2 FY25Sep 30, 2024	Q3 FY25Dec 31, 2024	Q4 FY25Mar 31, 2025	Q1 FY26Jun 30, 2025	Q2 FY26Sep 30, 2025	Q3 FY26Dec 31, 2025	Q4 FY26Mar 31, 2026	Q1 FY27Jun 30, 2026
Revenue	1,342	1,396	1,419	1,280	1,329	1,371	1,481*	1,391	1,460	1,496	1,588*	1,493
Cost of revenue	749	793	—	707	750	760	—	763	814	841	—	809
Cost of goods and services sold	692	738	836	—	—	—	year only	—	—	—	year only	—
Gross profit	594	603	583	572	579	610	—	628	646	656	—	684
Research and development	27	26	25*	26	27	27	28*	26	28	30	29*	29
Selling, general and administrative	381	361	152*	336	329	335	334*	354	350	352	352*	370
Total operating expenses	408	386	203*	387	359	365	425*	382	380	382	380*	398
Other operating income (expense)	—	—	—	—	—	0	—	0	—	(3)	—	0
Operating income (loss)	186	216	245*	186	220	245	216*	246	266	273	317*	286
Interest expense	37	39	36*	30	20	19	17*	16	15	15	15*	16
Other income (expense)	1	2	6*	1	1	2	4*	2	2	3	3*	3
Income tax expense (benefit)	34	38	37	35	44	55	50*	54	61	64	84*	73
Net income (loss)	115	141	(1)	145	150	174	146*	177	192	193	220*	200
Earnings per share, basic USD per share	1.17	1.42	(0.01)	1.47	1.52	1.76	1.48*	1.80	1.95	1.96	2.25*	—
Earnings per share, diluted USD per share	1.16	1.42	(0.01)	1.46	1.51	1.75	1.48*	1.79	1.94	1.96	2.23*	—
Weighted average shares, basic millions of shares	99	99	99*	99	99	98	98*	98	98	98	98*	98
Weighted average shares, diluted millions of shares	99	99	99*	99	99	99	99*	99	99	99	99*	98

Balance sheet

CSV

Fiscal quarters (STE's year ends in late March)

In millions of dollars	Q2 FY24Sep 30, 2023	Q3 FY24Dec 31, 2023	Q4 FY24Mar 31, 2024	Q1 FY25Jun 30, 2024	Q2 FY25Sep 30, 2024	Q3 FY25Dec 31, 2024	Q4 FY25Mar 31, 2025	Q1 FY26Jun 30, 2025	Q2 FY26Sep 30, 2025	Q3 FY26Dec 31, 2025	Q4 FY26Mar 31, 2026	Q1 FY27Jun 30, 2026
Cash and cash equivalents	214	196	207	198	172	155	172	280	319	424	440	482
Accounts receivable	940	964	1,008	893	923	915	1,044	947	947	991	1,093	1,013
Inventory	821	856	675	699	689	650	581	641	659	674	632	712
Total current assets	2,174	2,219	2,869	1,940	1,938	1,898	2,001	2,058	2,106	2,286	2,395	2,446
Property and equipment, net	1,744	1,844	1,765	1,834	1,930	1,922	1,957	2,055	2,092	2,133	2,161	2,172
Right-of-use asset	192	195	173	165	159	154	156	164	161	155	155	151
Goodwill	4,040	4,112	4,071	4,057	4,151	4,044	4,096	4,223	4,215	4,232	4,195	4,189
Total assets	11,281	11,435	11,064	10,109	10,242	10,008	10,147	10,405	10,411	10,591	10,737	10,736
Accounts payable	294	277	252	232	235	238	281	301	309	285	339	344
Accrued liabilities	307	318	320	287	307	335	368	371	360	405	402	421
Total current liabilities	873	914	931	834	805	891	1,022	927	889	922	1,145	1,283
Long-term debt	3,366	3,231	3,120	2,236	2,156	2,039	1,919	1,903	1,897	1,898	1,813	1,650
Lease liability, non-current	—	—	146	—	—	—	125	—	—	—	120	—
Total liabilities	5,091	5,007	4,748	3,738	3,632	3,580	3,531	3,435	3,388	3,424	3,540	3,515
Retained earnings	2,046	2,134	2,088	2,178	2,268	2,386	2,475	2,597	2,726	2,857	3,016	3,155
Total stockholders' equity	6,178	6,415	6,302	6,355	6,593	6,416	6,603	6,957	7,009	7,155	7,184	7,207
Total liabilities and equity	11,281	11,435	11,064	10,109	10,242	10,008	10,147	10,405	10,411	10,591	10,737	10,736
Common shares outstanding (cover page) millions of shares	99	99	99	99	99	98	98	98	98	98	98	98

Cash flows

CSV

Fiscal quarters (STE's year ends in late March)

In millions of dollars	Q2 FY24Sep 30, 2023	Q3 FY24Dec 31, 2023	Q4 FY24Mar 31, 2024	Q1 FY25Jun 30, 2024	Q2 FY25Sep 30, 2024	Q3 FY25Dec 31, 2024	Q4 FY25Mar 31, 2025	Q1 FY26Jun 30, 2025	Q2 FY26Sep 30, 2025	Q3 FY26Dec 31, 2025	Q4 FY26Mar 31, 2026	Q1 FY27Jun 30, 2026
Net income (loss)	115	141	(1)	145	150	174	146*	177	192	193	220*	200
Stock-based compensation	21*	15*	9*	11	21*	15*	10*	12	21*	16*	13*	13
Depreciation and amortization	152*	141*	134*	113	115*	126*	122*	119	122*	122*	123*	124
Net cash from operating activities	146*	291*	255*	304	251*	333*	261*	420	288*	298*	335*	367
Purchases of property and equipment	83*	119*	91*	108	102*	89*	71*	94	87*	99*	90*	88
Net cash from investing activities	(606)*	(119)*	(96)*	688	(105)*	(124)*	(70)*	(109)	(88)*	(99)*	(217)*	(109)
Share repurchases	0	2	0*	64	46	100*	0*	11	101*	50*	74*	116
Dividends paid	51*	51*	51*	51	56*	56*	56*	56	62*	62*	62*	61
Net cash from financing activities	470*	(198)*	(144)*	(999)	(181)*	(214)*	(178)*	(213)	(159)*	(98)*	(98)*	(214)
Net change in cash	5*	(18)*	11*	(9)	(26)*	(17)*	17*	108	40*	105*	16*	43

Compare with peers

SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
STERIS	482	1,493	367	97.5M	—	Q1 FY27 10-QJun 30, 2026
Insulet	535	802	88*	69.4M	—	Q2 FY26 10-QJun 30, 2026
Zimmer Biomet Holdings	410	2,177	448*	190.7M	—	Q2 FY26 10-QJun 30, 2026
GE HealthCare Technologies	2,826	5,513	907*	452.1M	—	Q3 FY26 10-QSep 30, 2026
Dexcom	961	1,345	326*	373.0M	—	Q3 FY26 10-QSep 30, 2026
Resmed	1,011	1,415	422	140.7M	—	Q1 FY27 10-QSep 30, 2026
Baxter International	1,975	2,976	558*	517.3M	—	Q3 FY26 10-QSep 30, 2026
West Pharmaceutical Services	464	875	190*	69.7M	—	Q3 FY26 10-QSep 30, 2026
MiniMed Group	207	843	(49)	281.3M	2.3 quarters	Q1 FY27 10-QJul 31, 2026

Not investment advice. Not affiliated with the U.S. SEC.